Ozanimod for Relapsing MS Shows Long-Term Safety, Efficacy :

"Serious infections did not vary by age, and there were too few serious events to identify any age-related trends by specific TEAE," the authors reported.

Related Keywords

San Francisco , California , United States , Tennessee , London , City Of , United Kingdom , Western University , Colorado , Vanderbilt University , Bruce Cree , Shailee Shah , Sclerosis Center , University Of California , Drug Administration , Vanderbilt University Medical Center , Consortium Of Multiple Sclerosis Centers , Multiple Sclerosis , Multiple Sclerosis Center , Multiple Sclerosis Ms , Us , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclerosis Relapsing Remitting , Drug Treatment Safety , Multiple Sclerosis Treatment , Als Treatment , Reatment Of Multiple Sclerosis , Reatment Of Ms , Multiple Sclerosis Progression , Als Progression , Ms Lesion , Ultiple Sclerosis Lesion , Ms Plaque , Ultiple Sclerosis Plaque , Multiple Sclerosis Relapse , ,